$25.83
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqGS:SGRY
Surgery Partners Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$2.74B | $2.54B | $2.23B | $1.86B | $1.83B | $1.77B | $1.31B | $1.12B | $936.31M | |
| GM % | Gross Margin % |
|
23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 22.75% | 26.76% | 28.51% | |
| OM | Operating Margin |
|
15.12% | 14.44% | 13.66% | 10.19% | 14.20% | 14.27% | 13.58% | 18.34% | 19.09% | |
| EPS | Earnings Per Share |
|
$0.00 | $1.00 | $0.16 | $-0.01 | $-1.22 | $-0.85 | $-0.80 | $-1.76 | $0.66 | $3.83 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | 0.00% | |
| Sha. | Shares |
|
125.86m | 124.97m | 87.68m | 49.01m | 48.52m | 48.17m | 48.11m | 48.03m | 48.16m | |
| OCF | Operating Cash Flow |
|
$293.80M | $158.80M | $87.10M | $246.90M | $129.50M | $144.60M | $120.90M | $125.24M | $84.48M | |
| FCF | Free Cash Flow |
|
$61.64M | $-68.60M | $-101.50M | $94.40M | $55.90M | $104.80M | $91.34M | $86.13M | $51.04M | |
| FCFS | Free Cash Flow Per Share |
|
$1.63 | $0.85 | $0.34 | $4.18 | $1.16 | $2.02 | $1.87 | $1.79 | $1.42 |
